Cat.#: ACPP-1217
| Despition | P2Y2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1418 | Human GAL Protein (AC1418) | 2 µg | inquiry |
| ACPP-1300 | GTP cyclohydrolase 1 Blocking Peptide (AC1300) | 250 µg | inquiry |
| ACPP-1341 | Pax2 Blocking Peptide (AC1341) | 250 µg | inquiry |
| ACPP-1578 | Human QPCT Protein (AC1578) | 2 µg | inquiry |
| ACPP-1792 | Rat CALB1 Protein (AC1792) | 1 µg | inquiry |
| ACPP-1037 | Recombinant Human Robo1 Protein (Fc Tag) (AC1037) | 50 µg | inquiry |
| ACPP-1390 | Human GDF11 Protein, His (AC1390) | 5 µg | inquiry |
| ACPP-1332 | GAD65 Blocking Peptide (AC1332) | 250 µg | inquiry |
| ACPP-1703 | Human PITPNA Protein (AC1703) | 5 µg | inquiry |
| ACPP-1413 | Human STX3 Protein (AC1413) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.